These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 215528

  • 1. Presence of Epstein-Barr virus specific IgA in saliva of nasopharyngeal carcinoma patients: their activity, origin and possible clinical value.
    Desgranges C, de-The G.
    IARC Sci Publ (1971); 1978; (20):459-69. PubMed ID: 215528
    [No Abstract] [Full Text] [Related]

  • 2. IgA and nasopharyngeal carcinoma.
    Desgranges C, De-The G.
    IARC Sci Publ (1971); 1978; (24 Pt 2):883-91. PubMed ID: 221410
    [No Abstract] [Full Text] [Related]

  • 3. Epstein-Barr virus-related serology in nasopharyngeal carcinoma and controls.
    Henle W, Henle G, Ho JH.
    IARC Sci Publ (1971); 1978; (20):427-37. PubMed ID: 215525
    [No Abstract] [Full Text] [Related]

  • 4. IgA antibodies to Epstein-Barr viral capsid antigens in saliva of nasopharyngeal carcinoma patients.
    Ho HC, Ng MH, Kwan HC.
    Br J Cancer; 1977 Jun; 35(6):888-90. PubMed ID: 194619
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. EBV specific secretory IgA in saliva of NPC patients. Presence of secretory piece in epithelial malignant cells.
    Desgranges C, Li JY, De-Thé.
    Int J Cancer; 1977 Dec 15; 20(6):881-6. PubMed ID: 201574
    [Abstract] [Full Text] [Related]

  • 7. Epstein--Barr virus-associated antibodies in IgG and IgA of nasopharyngeal carcinoma patients.
    Yang CS, Yang HM, Yeh YS, Lynn TC.
    Comp Immunol Microbiol Infect Dis; 1979 Dec 15; 2(2-3):167-75. PubMed ID: 228890
    [No Abstract] [Full Text] [Related]

  • 8. Antibodies to Epstein-Barr virus in nasopharyngeal carcinoma, tonsillar carcinoma and control groups.
    Oberender H, Nowak R, Donner A, Kunkel M, Gärtner L, Scholtz HJ.
    Acta Virol; 1983 May 15; 27(3):277-81. PubMed ID: 6138990
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Evaluation of antibodies to Epstein-Barr virus in Italian patients with nasopharyngeal carcinoma.
    Cevenini R, Donati M, Caliceti U, Moroni A, Tamba I, Rumpianesi F.
    J Infect; 1986 Mar 15; 12(2):127-31. PubMed ID: 3009628
    [Abstract] [Full Text] [Related]

  • 12. Detection of IgG and IgA antibodies to Epstein-Barr virus membrane antigen in sera from patients with nasopharyngeal carcinoma and from normal individuals.
    Zhu XX, Zeng Y, Wolf H.
    Int J Cancer; 1986 May 15; 37(5):689-91. PubMed ID: 3009331
    [Abstract] [Full Text] [Related]

  • 13. Epstein-Barr virus specific antibodies in patients with IgA nephropathy.
    Wu AY, Lau YK, Chia KB, Lim CH.
    Singapore Med J; 1988 Jun 15; 29(3):257-60. PubMed ID: 2847323
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Demonstration of IgG- and IgA-antibodies against Epstein-Barr virus-associated antigens with a microtiter enzyme immunoassay system. The determination of serum antibodies against the viral capsid antigen and the early antigen complex in the sera of tumor and infectious mononucleosis patients].
    Dölken G, Bitzer M, Bross KJ, Brugger W, Boldt C, Hirsch FW, Weitzmann U, Löhr GW.
    Dtsch Med Wochenschr; 1984 Nov 30; 109(48):1837-43. PubMed ID: 6094138
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The significance of serologic test for EB-virus antibody in occult type nasopharyngeal carcinoma.
    Furukawa M, Takimoto T, Morishita K, Komori T, Ishiguro H, Umeda R.
    Auris Nasus Larynx; 1983 Nov 30; 10(1):43-8. PubMed ID: 6311149
    [Abstract] [Full Text] [Related]

  • 18. [The clinical usefulness of the serological study of IgG antibodies and IgA against the antigens associated with the Epstein-Barr virus in patients with nasopharyngeal carcinoma].
    Amador García JM, Mendoza Montero J, Expósito Hernández J, Salinero Hernández J, Esquivias López-Cuerpo J, Ballesteros García P.
    Acta Otorrinolaringol Esp; 1992 Nov 30; 43(1):31-6. PubMed ID: 1316136
    [Abstract] [Full Text] [Related]

  • 19. A prospective study of antibodies to Epstein-Barr virus DNase and viral capsid antigen for prognostication of patients with nasopharyngeal carcinoma.
    Hsu MM, Chen JY, Chen CJ.
    Taiwan Yi Xue Hui Za Zhi; 1988 Oct 30; 87(10):984-8. PubMed ID: 2853721
    [No Abstract] [Full Text] [Related]

  • 20. Frequency and levels of antibodies to Epstein-Barr virus-specific DNase are elevated in patients with nasopharyngeal carcinoma.
    Cheng YC, Chen JY, Glaser R, Henle W.
    Proc Natl Acad Sci U S A; 1980 Oct 30; 77(10):6162-5. PubMed ID: 6255477
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.